Earnings call transcript: Heritage Financial tops Q3 2026 estimates as margin widens

Heritage Financial reported Q3 2026 EPS of $0.55 versus $0.51 expected and revenue of $86.51 million versus $86.11 million; net interest margin expanded to 4.05% from 3.99% in Q2. Loans grew $133 million and deposits $148 million, while the Kitsap Bank systems conversion helped reduce merger-related costs; shares rose 2.94% to $28.50 in pre-market trading. Management expects mid-single-digit loan growth over the next couple of quarters and continued margin improvement, but non-accrual loans increased by $16.6 million to just over $32 million, 2027 expenses are expected to rise, and buybacks may slow amid elevated CRE concentration.

Analysis

HFWA’s upside is increasingly dependent on execution rather than merger cleanup: the Kitsap conversion removes a drag, but the next earnings leg must come from asset repricing outrunning deposit-cost pressure. That spread is not assured—the bank says deposit costs began rising within the quarter, while higher loan coupons can also induce cash-rich borrowers to repay, weakening balance growth. Securities reinvestment offers a gradual offset, not an immediate step-change.

The earnings beat is therefore better quality than a pure accounting surprise, but its durability is vulnerable to the credit and expense mix. Rising non-accruals and criticized loans are early-warning indicators even with low realized losses and partial guarantees on the largest cited relationship. CRE concentration also constrains buybacks, reducing a potential source of EPS support just as core expenses and commercial-banking technology costs rise in 2027. AFS marks have already weighed on tangible common equity, limiting the comfort investors should take from headline capital ratios.

Near term, post-earnings strength may be capped: the shares are already near the upper end of their annual range, while guidance implies sequential margin progress but not immunity to funding repricing. Over 1–3 months, watch deposit costs, criticized-credit migration, loan payoffs versus originations, and Q4 expenses. Over 6–18 months, the key question is whether credit normalization and operating investment absorb the integration savings. The contrarian risk is treating platform completion and a low screen-based growth multiple as proof of cheapness; neither establishes through-cycle earnings power. Thesis weakens materially if non-accruals keep rising, NIM stalls as funding costs reset, or core costs exceed the indicated run rate.

Key Decisions for Investors

• Do not chase the initial post-release move. For a tactical position, consider a small HFWA long only after the reaction settles and subsequent disclosures confirm stable-to-improving NIM alongside contained credit migration; the upside case is continued spread accretion and operating leverage, while the downside is credit-cost/expense revisions compressing earnings and the multiple.
• Use the next quarter as a validation point: track interest-bearing deposit cost versus loan and securities yields, criticized and non-accrual balances, and net loan growth after payoffs. Reassess or exit the long thesis if funding costs rise faster than asset yields or non-accruals continue to expand without clear resolutions.
• Treat buybacks as limited near-term support, not a catalyst: elevated CRE concentration may restrain repurchases, and the 2027 online-banking spend plus ordinary cost inflation offsets some merger-cost relief. Verify the eventual 2027 expense outlook before underwriting material EPS leverage.
• No direct META or broad Nasdaq trade follows from the HFWA-specific earnings detail; the article’s market-risk framing does not establish a causal link to this bank’s fundamentals.